Loading…
Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes
Cyclophosphamide (CYP) and methotrexate (MTX) have been evaluated for their ability to induce toxicity in human peripheral blood lymphocytes (PBLs) and the protective role of mitochondrial and lysosomal stabilizing agents. The potential toxicity effects of CYP and MTX were measured in vitro by cellu...
Saved in:
Published in: | Human & experimental toxicology 2019-11, Vol.38 (11), p.1266-1274 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3 |
container_end_page | 1274 |
container_issue | 11 |
container_start_page | 1266 |
container_title | Human & experimental toxicology |
container_volume | 38 |
creator | Salimi, A Pirhadi, R Jamali, Z Ramazani, M Yousefsani, BS Pourahmad, J |
description | Cyclophosphamide (CYP) and methotrexate (MTX) have been evaluated for their ability to induce toxicity in human peripheral blood lymphocytes (PBLs) and the protective role of mitochondrial and lysosomal stabilizing agents. The potential toxicity effects of CYP and MTX were measured in vitro by cellular parameters assays such as cellular viability, reactive oxygen species (ROS) formation, mitochondrial membrane permeability transition (mitochondrial membrane potential (MMP)) collapse, lysosomal membrane damage, intracellular reduced glutathione (GSH), extracellular oxidized glutathione (GSSG), and lipid peroxidation. Separately, human lymphocytes were treated with concentrations of 0.1, 0.2, 0.4, 0.8, and 1.6 ng/mL for CYP and 1, 2, 5, and 10 µg/mL for MTX for 6 h. Statistical evaluations showed that CYP and MTX significantly decreased the cell viability at the three highest concentrations when compared with both the negative and solvent controls. In addition, CYP and MTX were significantly induced ROS formation, MMP collapse, lysosomal membrane damage, lipid peroxidation, and GSH depletion compared with the controls. Mitochondrial and lysosomal protective agents like cyclosporine A and chloroquine, respectively, decreased cytotoxicity and oxidative stress induced by CYP and MTX. The present results indicate that CYP and MTX are toxic to human PBLs and their toxicity could be ameliorated by mitochondrial and lysosomal protective agents. |
doi_str_mv | 10.1177/0960327119871096 |
format | article |
fullrecord | <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_journals_2287031624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0960327119871096</sage_id><sourcerecordid>2287031624</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3</originalsourceid><addsrcrecordid>eNp1kc1u1TAQhS0EoreFPSsUiXXAEzt2skQVf1IRG1hHE3tCXCXxxXZQ8zo8Kc69pUhIrOzRfOecsYexF8BfA2j9hreKi0oDtI2GXDxiB5Bal7zl4jE77O1y71-wyxhvOeeqreEpuxAgpdKNPLBfn13yZvSLDQ6nAhdbTFv00c-5OgafyCT3kwr8TkuKBc40OR8wUWG25JO_c8al7aTLd4snOKZAMRZusashW_Rbhs3kj6OPxxFnZ-kkmCmNPqN3u51binGdcSn6yft9iDnjOYPiM_ZkwCnS8_vzin17_-7r9cfy5suHT9dvb0ojVJ1KGDT21ALHWjUADfVcctFKW9OgBB9Aix7JVqgUIRLWpu8lSKokWDSaxBV7dfbNz_6xUkzdrV_DkiO7qmo0F6AqmSl-pkzwMQYaumNwM4atA97tS-n-XUqWvLw3XvuZ7IPgzxYyUJ6BmL_5b-p_DX8DMrCaAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2287031624</pqid></control><display><type>article</type><title>Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes</title><source>Sage Journals GOLD Open Access 2024</source><creator>Salimi, A ; Pirhadi, R ; Jamali, Z ; Ramazani, M ; Yousefsani, BS ; Pourahmad, J</creator><creatorcontrib>Salimi, A ; Pirhadi, R ; Jamali, Z ; Ramazani, M ; Yousefsani, BS ; Pourahmad, J</creatorcontrib><description>Cyclophosphamide (CYP) and methotrexate (MTX) have been evaluated for their ability to induce toxicity in human peripheral blood lymphocytes (PBLs) and the protective role of mitochondrial and lysosomal stabilizing agents. The potential toxicity effects of CYP and MTX were measured in vitro by cellular parameters assays such as cellular viability, reactive oxygen species (ROS) formation, mitochondrial membrane permeability transition (mitochondrial membrane potential (MMP)) collapse, lysosomal membrane damage, intracellular reduced glutathione (GSH), extracellular oxidized glutathione (GSSG), and lipid peroxidation. Separately, human lymphocytes were treated with concentrations of 0.1, 0.2, 0.4, 0.8, and 1.6 ng/mL for CYP and 1, 2, 5, and 10 µg/mL for MTX for 6 h. Statistical evaluations showed that CYP and MTX significantly decreased the cell viability at the three highest concentrations when compared with both the negative and solvent controls. In addition, CYP and MTX were significantly induced ROS formation, MMP collapse, lysosomal membrane damage, lipid peroxidation, and GSH depletion compared with the controls. Mitochondrial and lysosomal protective agents like cyclosporine A and chloroquine, respectively, decreased cytotoxicity and oxidative stress induced by CYP and MTX. The present results indicate that CYP and MTX are toxic to human PBLs and their toxicity could be ameliorated by mitochondrial and lysosomal protective agents.</description><identifier>ISSN: 0960-3271</identifier><identifier>EISSN: 1477-0903</identifier><identifier>DOI: 10.1177/0960327119871096</identifier><identifier>PMID: 31446784</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adolescent ; Adult ; Antineoplastic Agents - toxicity ; Blood ; Butylated Hydroxytoluene - pharmacology ; Cell Survival - drug effects ; Cell viability ; Cells, Cultured ; Chloroquine ; Chloroquine - pharmacology ; Collapse ; Cyclophosphamide ; Cyclophosphamide - toxicity ; Cyclosporine - pharmacology ; Cyclosporins ; Cytotoxicity ; Depletion ; Glutathione ; Glutathione - metabolism ; Humans ; Immunosuppressive Agents - toxicity ; Lipid peroxidation ; Lipids ; Lymphocytes ; Lymphocytes - drug effects ; Lymphocytes - metabolism ; Lysosomes - drug effects ; Membrane permeability ; Membrane potential ; Methotrexate ; Methotrexate - toxicity ; Mitochondria ; Mitochondria - drug effects ; Mitochondria - physiology ; Oxidation ; Oxidative stress ; Oxidative Stress - drug effects ; Peripheral blood ; Peroxidation ; Protective Agents - pharmacology ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Stabilizers (agents) ; Toxicity ; Young Adult</subject><ispartof>Human & experimental toxicology, 2019-11, Vol.38 (11), p.1266-1274</ispartof><rights>The Author(s) 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3</citedby><cites>FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3</cites><orcidid>0000-0003-3026-6398 ; 0000-0002-4555-4168</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0960327119871096$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0960327119871096$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21966,27853,27924,27925,44945,45333</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/0960327119871096?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31446784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salimi, A</creatorcontrib><creatorcontrib>Pirhadi, R</creatorcontrib><creatorcontrib>Jamali, Z</creatorcontrib><creatorcontrib>Ramazani, M</creatorcontrib><creatorcontrib>Yousefsani, BS</creatorcontrib><creatorcontrib>Pourahmad, J</creatorcontrib><title>Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes</title><title>Human & experimental toxicology</title><addtitle>Hum Exp Toxicol</addtitle><description>Cyclophosphamide (CYP) and methotrexate (MTX) have been evaluated for their ability to induce toxicity in human peripheral blood lymphocytes (PBLs) and the protective role of mitochondrial and lysosomal stabilizing agents. The potential toxicity effects of CYP and MTX were measured in vitro by cellular parameters assays such as cellular viability, reactive oxygen species (ROS) formation, mitochondrial membrane permeability transition (mitochondrial membrane potential (MMP)) collapse, lysosomal membrane damage, intracellular reduced glutathione (GSH), extracellular oxidized glutathione (GSSG), and lipid peroxidation. Separately, human lymphocytes were treated with concentrations of 0.1, 0.2, 0.4, 0.8, and 1.6 ng/mL for CYP and 1, 2, 5, and 10 µg/mL for MTX for 6 h. Statistical evaluations showed that CYP and MTX significantly decreased the cell viability at the three highest concentrations when compared with both the negative and solvent controls. In addition, CYP and MTX were significantly induced ROS formation, MMP collapse, lysosomal membrane damage, lipid peroxidation, and GSH depletion compared with the controls. Mitochondrial and lysosomal protective agents like cyclosporine A and chloroquine, respectively, decreased cytotoxicity and oxidative stress induced by CYP and MTX. The present results indicate that CYP and MTX are toxic to human PBLs and their toxicity could be ameliorated by mitochondrial and lysosomal protective agents.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antineoplastic Agents - toxicity</subject><subject>Blood</subject><subject>Butylated Hydroxytoluene - pharmacology</subject><subject>Cell Survival - drug effects</subject><subject>Cell viability</subject><subject>Cells, Cultured</subject><subject>Chloroquine</subject><subject>Chloroquine - pharmacology</subject><subject>Collapse</subject><subject>Cyclophosphamide</subject><subject>Cyclophosphamide - toxicity</subject><subject>Cyclosporine - pharmacology</subject><subject>Cyclosporins</subject><subject>Cytotoxicity</subject><subject>Depletion</subject><subject>Glutathione</subject><subject>Glutathione - metabolism</subject><subject>Humans</subject><subject>Immunosuppressive Agents - toxicity</subject><subject>Lipid peroxidation</subject><subject>Lipids</subject><subject>Lymphocytes</subject><subject>Lymphocytes - drug effects</subject><subject>Lymphocytes - metabolism</subject><subject>Lysosomes - drug effects</subject><subject>Membrane permeability</subject><subject>Membrane potential</subject><subject>Methotrexate</subject><subject>Methotrexate - toxicity</subject><subject>Mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - physiology</subject><subject>Oxidation</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Peripheral blood</subject><subject>Peroxidation</subject><subject>Protective Agents - pharmacology</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Stabilizers (agents)</subject><subject>Toxicity</subject><subject>Young Adult</subject><issn>0960-3271</issn><issn>1477-0903</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1TAQhS0EoreFPSsUiXXAEzt2skQVf1IRG1hHE3tCXCXxxXZQ8zo8Kc69pUhIrOzRfOecsYexF8BfA2j9hreKi0oDtI2GXDxiB5Bal7zl4jE77O1y71-wyxhvOeeqreEpuxAgpdKNPLBfn13yZvSLDQ6nAhdbTFv00c-5OgafyCT3kwr8TkuKBc40OR8wUWG25JO_c8al7aTLd4snOKZAMRZusashW_Rbhs3kj6OPxxFnZ-kkmCmNPqN3u51binGdcSn6yft9iDnjOYPiM_ZkwCnS8_vzin17_-7r9cfy5suHT9dvb0ojVJ1KGDT21ALHWjUADfVcctFKW9OgBB9Aix7JVqgUIRLWpu8lSKokWDSaxBV7dfbNz_6xUkzdrV_DkiO7qmo0F6AqmSl-pkzwMQYaumNwM4atA97tS-n-XUqWvLw3XvuZ7IPgzxYyUJ6BmL_5b-p_DX8DMrCaAw</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Salimi, A</creator><creator>Pirhadi, R</creator><creator>Jamali, Z</creator><creator>Ramazani, M</creator><creator>Yousefsani, BS</creator><creator>Pourahmad, J</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7ST</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>SOI</scope><orcidid>https://orcid.org/0000-0003-3026-6398</orcidid><orcidid>https://orcid.org/0000-0002-4555-4168</orcidid></search><sort><creationdate>201911</creationdate><title>Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes</title><author>Salimi, A ; Pirhadi, R ; Jamali, Z ; Ramazani, M ; Yousefsani, BS ; Pourahmad, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antineoplastic Agents - toxicity</topic><topic>Blood</topic><topic>Butylated Hydroxytoluene - pharmacology</topic><topic>Cell Survival - drug effects</topic><topic>Cell viability</topic><topic>Cells, Cultured</topic><topic>Chloroquine</topic><topic>Chloroquine - pharmacology</topic><topic>Collapse</topic><topic>Cyclophosphamide</topic><topic>Cyclophosphamide - toxicity</topic><topic>Cyclosporine - pharmacology</topic><topic>Cyclosporins</topic><topic>Cytotoxicity</topic><topic>Depletion</topic><topic>Glutathione</topic><topic>Glutathione - metabolism</topic><topic>Humans</topic><topic>Immunosuppressive Agents - toxicity</topic><topic>Lipid peroxidation</topic><topic>Lipids</topic><topic>Lymphocytes</topic><topic>Lymphocytes - drug effects</topic><topic>Lymphocytes - metabolism</topic><topic>Lysosomes - drug effects</topic><topic>Membrane permeability</topic><topic>Membrane potential</topic><topic>Methotrexate</topic><topic>Methotrexate - toxicity</topic><topic>Mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - physiology</topic><topic>Oxidation</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Peripheral blood</topic><topic>Peroxidation</topic><topic>Protective Agents - pharmacology</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Stabilizers (agents)</topic><topic>Toxicity</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salimi, A</creatorcontrib><creatorcontrib>Pirhadi, R</creatorcontrib><creatorcontrib>Jamali, Z</creatorcontrib><creatorcontrib>Ramazani, M</creatorcontrib><creatorcontrib>Yousefsani, BS</creatorcontrib><creatorcontrib>Pourahmad, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environment Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Environment Abstracts</collection><jtitle>Human & experimental toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Salimi, A</au><au>Pirhadi, R</au><au>Jamali, Z</au><au>Ramazani, M</au><au>Yousefsani, BS</au><au>Pourahmad, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes</atitle><jtitle>Human & experimental toxicology</jtitle><addtitle>Hum Exp Toxicol</addtitle><date>2019-11</date><risdate>2019</risdate><volume>38</volume><issue>11</issue><spage>1266</spage><epage>1274</epage><pages>1266-1274</pages><issn>0960-3271</issn><eissn>1477-0903</eissn><abstract>Cyclophosphamide (CYP) and methotrexate (MTX) have been evaluated for their ability to induce toxicity in human peripheral blood lymphocytes (PBLs) and the protective role of mitochondrial and lysosomal stabilizing agents. The potential toxicity effects of CYP and MTX were measured in vitro by cellular parameters assays such as cellular viability, reactive oxygen species (ROS) formation, mitochondrial membrane permeability transition (mitochondrial membrane potential (MMP)) collapse, lysosomal membrane damage, intracellular reduced glutathione (GSH), extracellular oxidized glutathione (GSSG), and lipid peroxidation. Separately, human lymphocytes were treated with concentrations of 0.1, 0.2, 0.4, 0.8, and 1.6 ng/mL for CYP and 1, 2, 5, and 10 µg/mL for MTX for 6 h. Statistical evaluations showed that CYP and MTX significantly decreased the cell viability at the three highest concentrations when compared with both the negative and solvent controls. In addition, CYP and MTX were significantly induced ROS formation, MMP collapse, lysosomal membrane damage, lipid peroxidation, and GSH depletion compared with the controls. Mitochondrial and lysosomal protective agents like cyclosporine A and chloroquine, respectively, decreased cytotoxicity and oxidative stress induced by CYP and MTX. The present results indicate that CYP and MTX are toxic to human PBLs and their toxicity could be ameliorated by mitochondrial and lysosomal protective agents.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>31446784</pmid><doi>10.1177/0960327119871096</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-3026-6398</orcidid><orcidid>https://orcid.org/0000-0002-4555-4168</orcidid></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 0960-3271 |
ispartof | Human & experimental toxicology, 2019-11, Vol.38 (11), p.1266-1274 |
issn | 0960-3271 1477-0903 |
language | eng |
recordid | cdi_proquest_journals_2287031624 |
source | Sage Journals GOLD Open Access 2024 |
subjects | Adolescent Adult Antineoplastic Agents - toxicity Blood Butylated Hydroxytoluene - pharmacology Cell Survival - drug effects Cell viability Cells, Cultured Chloroquine Chloroquine - pharmacology Collapse Cyclophosphamide Cyclophosphamide - toxicity Cyclosporine - pharmacology Cyclosporins Cytotoxicity Depletion Glutathione Glutathione - metabolism Humans Immunosuppressive Agents - toxicity Lipid peroxidation Lipids Lymphocytes Lymphocytes - drug effects Lymphocytes - metabolism Lysosomes - drug effects Membrane permeability Membrane potential Methotrexate Methotrexate - toxicity Mitochondria Mitochondria - drug effects Mitochondria - physiology Oxidation Oxidative stress Oxidative Stress - drug effects Peripheral blood Peroxidation Protective Agents - pharmacology Reactive oxygen species Reactive Oxygen Species - metabolism Stabilizers (agents) Toxicity Young Adult |
title | Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A57%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrial%20and%20lysosomal%20protective%20agents%20ameliorate%20cytotoxicity%20and%20oxidative%20stress%20induced%20by%20cyclophosphamide%20and%20methotrexate%20in%20human%20blood%20lymphocytes&rft.jtitle=Human%20&%20experimental%20toxicology&rft.au=Salimi,%20A&rft.date=2019-11&rft.volume=38&rft.issue=11&rft.spage=1266&rft.epage=1274&rft.pages=1266-1274&rft.issn=0960-3271&rft.eissn=1477-0903&rft_id=info:doi/10.1177/0960327119871096&rft_dat=%3Cproquest_AFRWT%3E2287031624%3C/proquest_AFRWT%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2287031624&rft_id=info:pmid/31446784&rft_sage_id=10.1177_0960327119871096&rfr_iscdi=true |